CSS LLC/IL - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$412,000
-94.5%
22,600
-94.5%
0.02%
-94.1%
Q4 2020$7,532,000
-3.7%
413,809
-5.6%
0.29%
-21.9%
Q3 2020$7,820,000
-3.8%
438,409
-3.2%
0.37%
-19.6%
Q2 2020$8,125,000
+38.3%
453,058
+17.1%
0.46%
-0.6%
Q1 2020$5,875,000
-16.7%
386,960
+8.3%
0.46%
+18.4%
Q4 2019$7,052,000
+35.5%
357,386
+18.1%
0.39%
+17.1%
Q3 2019$5,205,000
-10.9%
302,598
-8.3%
0.33%
-0.6%
Q2 2019$5,841,000
+9.1%
330,072
+25.5%
0.34%
+4.3%
Q1 2019$5,356,000262,9110.32%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders